| __timestamp | Alpine Immune Sciences, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 2287709 | 381287000 |
| Thursday, January 1, 2015 | 6844000 | 452612000 |
| Friday, January 1, 2016 | 8586000 | 316800000 |
| Sunday, January 1, 2017 | 6079000 | 330100000 |
| Monday, January 1, 2018 | 8362000 | 265800000 |
| Tuesday, January 1, 2019 | 9467000 | 336200000 |
| Wednesday, January 1, 2020 | 10899000 | 423900000 |
| Friday, January 1, 2021 | 14560000 | 467000000 |
| Saturday, January 1, 2022 | 17968000 | 487000000 |
| Sunday, January 1, 2023 | 22222000 | 477100000 |
Unleashing insights
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for financial health. United Therapeutics Corporation and Alpine Immune Sciences, Inc. offer a fascinating comparison in this regard. Over the past decade, United Therapeutics has consistently maintained higher SG&A expenses, peaking at nearly $487 million in 2022. In contrast, Alpine Immune Sciences, with a more modest budget, saw its SG&A costs rise from approximately $2.3 million in 2014 to $22.2 million in 2023, marking a tenfold increase. This growth reflects Alpine's strategic investments in scaling operations. Meanwhile, United Therapeutics' expenses have fluctuated, indicating a dynamic approach to cost management. As both companies navigate the biotech landscape, their differing strategies in optimizing SG&A costs highlight the diverse paths to achieving operational efficiency and market success.
Gilead Sciences, Inc. vs United Therapeutics Corporation: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of United Therapeutics Corporation and Genmab A/S
United Therapeutics Corporation and Bio-Techne Corporation: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: United Therapeutics Corporation vs Lantheus Holdings, Inc.
SG&A Efficiency Analysis: Comparing United Therapeutics Corporation and Catalyst Pharmaceuticals, Inc.
Comparing SG&A Expenses: United Therapeutics Corporation vs Bausch Health Companies Inc. Trends and Insights
United Therapeutics Corporation vs Vericel Corporation: SG&A Expense Trends
United Therapeutics Corporation vs Xencor, Inc.: SG&A Expense Trends
Selling, General, and Administrative Costs: Summit Therapeutics Inc. vs Alpine Immune Sciences, Inc.
Comparing SG&A Expenses: Alkermes plc vs Alpine Immune Sciences, Inc. Trends and Insights
Alpine Immune Sciences, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Alpine Immune Sciences, Inc. vs Viridian Therapeutics, Inc. Trends and Insights